Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 60, Issue 2, 2000, Pages 149-159

  Holmström, Henrik ^a   Hall, C ^a   Stokke, O ^a   Thaulow, E ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anthracyclin; Atrial natriuretic peptide; Glomerular filtration rate; Heart failure; Heart ventricle; Peptides; Reference values

Indexed keywords

ANTHRACYCLINE; ATRIAL NATRIURETIC FACTOR; HORMONE PRECURSOR;

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER; CHILD; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; INFANT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEIN DETERMINATION; URINARY TRACT DISEASE;

GLOMERULUS;

EID: 0034077958     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510050184976     Document Type: Article

References (31)

1. 1 Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC, Jr. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988; 62: 191-5.
2. 2 Nicholls MG. The natriuretic peptides in heart failure. J Intern Med 1994; 235: 515-26.
3. 3 Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 1992; 44: 479-602.
4. 4 Dickstein K, Larsen AI, Bonarjee V, Thoresen M, Aarsland T, Hall C. Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure. Am J Cardiol 1995; 76: 679-83.
5. 5 Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993; 341: 1105-9.
6. 6 Yandle TG. Biochemistry of natriuretic peptides. J Intern Med 1994; 235: 561-76.
7. 7 Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-8.
8. 8 Sundsfjord JA, Thibault G, Larochelle P, Cantin M. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 1988; 66: 605-10.
9. 9 Katsube N, Schwartz D, Needleman P. Atriopeptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content. J Pharmacol Exp Ther 1986; 239: 474-9.
10. 10 Bonarjee VV, Omland T, Nilsen DW, Caidahl K, Sundsfjord JA, Dickstein K. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function. Br Heart J 1995; 73: 511-6.
11. 11 Holmstrom H, Thaulow E, Stokke O, Lindberg H, Hall C. Serum N-terminal proatrial natriuretic factor in children with congenital heart disease. Eur Heart J 1996; 17: 1737-46.
12. 12 Holmström H, Hall C, Stokke O, Lindberg H, Thaulow E. Hemodynamic background of the elevation of N-terminal natriuretic peptide prohormone in children with congenital heart disease. Card Young 1999; 9: 141-9.
13. 13 Sjoberg S, Hellsten S, Almen T, Golman K, Gronberg T. Estimating kidney function during urography. Comparison of contrast medium clearance and simultaneous 51Cr-EDTA clearance. Acta Radiol 1987; 28: 587-92.
14. 14 Stake G, Monn E, Rootwelt K, Monclair T. A single plasma sample method for estimation of the glomerular filtration rate in infants and children using iohexol. II: Establishment of the optimal plasma sampling time and a comparison with the 99Tcm-DTPA method. Scand J Clin Lab Invest 1991; 51: 343-8.
15. 15 Boijsen M, Granerus G, Jacobsson L, Bjorneld L, Aurell M, Tylen U. Glomerular filtration rate estimated after multiple injections of contrast medium during angiography. Acta Radiol 1988; 29: 669-74.
16. 16 Haycock GB, Dalton N Laboratory investigation. In: Holliday MA, Barratt TM, Avner ED, editors. Pediatric nephrology. 3rd ed. Baltimore: Williams and Wilkins, 1994: 397-420
17. 17 Dahle M, Simonsen S, Hall C, Kjekshus J. Power of plasma N-terminal proatrial natriuretic factor to determine haemodynamics in patients with cardiac disease: relation to serum creatinine. Scand J Clin Lab Invest 1998; 58: 395-404.
18. 18 Kikuchi K, Nakao K, Hayashi K, Morii N, Sugawara A, Sakamoto M, et al. Ontogeny of atrial natriuretic polypeptide in the human heart. Acta Endocrinol 1987; 115: 211-7.
19. 19 Chien R. Signaling mechanisms for the activation of an embryonic gene program during the hypertrophy of cardiac ventricular muscle. Basic Res Cardiol 1992; 87 Suppl; 2: 49-58.
20. 20 Jougasaki M, Yasue H, Okumura K, Mukoyama M, Saito Y, Nakao K, et al. Atrial natriuretic peptide in the ventricles of patients with dilated cardiomyopathy and human foetuses. Histochem J 1989; 21: 715-20.
21. 21 Ekblad H, Kero P, Vuolteenaho O, Arjamaa O, Korvenranta H, Shaffer SG. Atrial natriuretic peptide in the preterm infant. Lack of correlation with natriuresis and diuresis. Acta Paediatr 1992; 81: 978-82.
22. 22 Stephenson TJ, Broughton Pipkin F, Hetmanski D, Yoxall B. Atrial natriuretic peptide in the preterm newborn. Biol Neonate 1994; 66: 22-32.
23. 23 Ikemoto Y, Nogi S, Teraguchi M, Kojima T, Hirata Y, Kobayashi Y. Early changes in plasma brain and atrial natriuretic peptides in premature infants: correlation with pulmonary arterial pressure. Early Hum Dev 1996; 46: 55-62.
24. 24 Weil J, Bidlingmaier F, Dohlemann C, Kuhnle U, Strom T, Lang RE. Comparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseases. Pediatr Res 1986; 20: 1328-31.
25. 25 Kikuchi K, Shiomi M, Horie K, Ohie T, Nakao K, Imura H, et al. Plasma atrial natriuretic polypeptide concentration in healthy children from birth to adolescence. Acta Paediatr Scand 1988; 77: 380-4.
26. 26 Heilbron DC, Holliday MA, al-Dahwi A, Kogan BA. Expressing glomerular filtration rate in children. Pediatr Nephrol 1991; 5: 5-11.
27. 27 Edwards BS, Ackermann DM, Lee ME, Reeder GS, Wold LE, Burnett JC, Jr. Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure. J Clin Invest 1988; 81: 82-6.
28. 28 Yasue H, Obata K, Okumura K, Kurose M, Ogawa H, Matsuyama K, et al. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J Clin Invest 1989; 83: 46-51.
29. 29 Neri B, De Scalzi M, De Leonardis V, Gemelli MT, Ghezzi P, Pacini P. Preliminary study on behaviour of atrial natriuretic factor in anthracycline-related cardiac toxicity. Int J Clin Pharmacol Res 1991; 11: 75-81.
30. 30 Bauch M, Ester A, Kimura B, Victorica BE, Kedar A, Phillips MI. Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects. Cancer 1992; 69: 1492-7.
31. 31 Meberg A, Otterstad J, Hals J, Sørland S. Early clinical screening of neonates for congenital heart defects: the cases we miss. Card Young 1999; 9: 169-74.